Valuation: Zalicus Inc

Market Cap 7L 6L 6L 6L 10.48L 7.11Cr 10.66L 71.4L 27.96L 3.55Cr 28.03L 27.41L 12Cr P/E 2014
-0.83x
P/E 2015 -1.35x
Enterprise Value -1.59Cr -1.38Cr -1.29Cr -1.19Cr -2.24Cr -151.89Cr -2.28Cr -15Cr -5.97Cr -76Cr -5.99Cr -5.85Cr -249.84Cr EV / Sales 2014
14,77,02,94,750x
EV / Sales 2015 8,36,58,631x
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%+0.14%-2.06%+14.33% 4.82TCr
-2.71%-2.99%+398.09%+472.12% 3.88TCr
-0.71%+9.45%+27.90%+7.89% 3.84TCr
-0.71%-3.72%+4.94%+52.45% 3.49TCr
-2.41%+1.96%+11.68%+38.17% 2.92TCr
-0.66%-2.73%+35.50%+122.17% 1.6TCr
-0.19%-3.93% - - 1.6TCr
-0.62%+1.23%+2.76%+15.05% 1.35TCr
-3.15%-6.14%-4.82%-36.90% 1.22TCr
Average -1.28%-0.66%+59.25%+85.66% 2.75TCr
Weighted average by Cap. -1.23%+0.15%+75.56%+103.60%

Financials

2014 2015
Net sales 0 0 0 0 0.01 0.38 0.01 0.04 0.01 0.19 0.02 0.01 0.63 0.7 0.61 0.57 0.52 0.98 66.82 1 6.71 2.63 33.32 2.63 2.57 109.9
Net income -4.18Cr -3.64Cr -3.4Cr -3.12Cr -5.88Cr -398.84Cr -5.98Cr -40Cr -16Cr -198.9Cr -16Cr -15Cr -656.03Cr -5.22Cr -4.54Cr -4.23Cr -3.89Cr -7.33Cr -497.44Cr -7.46Cr -50Cr -20Cr -248.06Cr -20Cr -19Cr -818.2Cr
Net Debt -1.42Cr -1.23Cr -1.15Cr -1.06Cr -1.99Cr -135.16Cr -2.03Cr -14Cr -5.31Cr -67Cr -5.33Cr -5.21Cr -222.31Cr -1.67Cr -1.45Cr -1.35Cr -1.24Cr -2.34Cr -159.01Cr -2.38Cr -16Cr -6.25Cr -79Cr -6.27Cr -6.13Cr -261.54Cr
Logo Zalicus Inc
EPIRUS Biopharmaceuticals Inc is a United States-based company. The Company operates as a pharmaceutical preparation manufacturer.
Employees
-